Galera Therapeutics, Inc. (OTCMKTS: GRTX) related to its merger with Obsidian Therapeutics, Inc. Upon completion of the proposed transaction, Galera shareholders will own approximately 1.8% of the combined company.
Galera Therapeutics, Inc. (OTCMKTS: GRTX) related to its merger with Obsidian Therapeutics, Inc. Upon completion of the proposed transaction, Galera shareholders will own approximately 1.8% of the combined company.